Impact of Down syndrome on the performance of neonatal screening assays for severe primary immunodeficiency diseases.
- nov 2014
- Esther de Vries
- 1
- 3794
ARTIKEL: Verstegen RH, Borte S, Bok LA, van Zwieten PH, von Döbeln U, Hammarström L, de Vries E. J Allergy Clin Immunol. 2014 Apr;133(4):1208-11.
Bijlagen
| titel | toegevoegd | door | opties | |
|---|---|---|---|---|
| Verstegen_et_al_JACI.pdf | nov 2014 |  |
Verken
Influenza A/H1N1 vaccination respons is inadequate in Down syndrome children when the latest latest cut-off values are used.
nov 2014ARTIKEL: Kusters MA, Bok LA, Bolz WEA, Huijskens EGW, Peeters MF, de Vries E. Pediatr Infect Dis J. 20...
Down syndrome B-lymphocyte subpopulations, intrinsic defect or decreased T-lymphocyte help.
nov 2014ARTIKEL: Verstegen RH, Kusters MA, Gemen EF, de Vries E. Pediatr Res. 2010 May;67(5):563-9.
Towards an integrated Immunology care chain. A study to optimize diagnosis and treatment of patients with primary immunodeficiency diseases.
jul 2014AFSTUDEERSCRIPTIE: Masters program Management, Policy Analysis and Entrepreneurship in Health and Lif...